Literature DB >> 22780864

Effect on ligament marker expression by direct-contact co-culture of mesenchymal stem cells and anterior cruciate ligament cells.

Jose A Canseco1, Koji Kojima, Ashley R Penvose, Jason D Ross, Haruko Obokata, Andreas H Gomoll, Charles A Vacanti.   

Abstract

Ligament and tendon repair is an important topic in orthopedic tissue engineering; however, the cell source for tissue regeneration has been a controversial issue. Until now, scientists have been split between the use of primary ligament fibroblasts or marrow-derived mesenchymal stem cells (MSCs). The objective of this study was to show that a co-culture of anterior cruciate ligament (ACL) cells and MSCs has a beneficial effect on ligament regeneration that is not observed when utilizing either cell source independently. Autologous ACL cells (ACLcs) and MSCs were isolated from Yorkshire pigs, expanded in vitro, and cultured in multiwell plates in varying %ACLcs/%MSCs ratios (100/0, 75/25, 50/50, 25/75, and 0/100) for 2 and 4 weeks. Quantitative mRNA expression analysis and immunofluorescent staining for ligament markers Collagen type I (Collagen-I), Collagen type III (Collagen-III), and Tenascin-C were performed. We show that Collagen-I and Tenascin-C expression is significantly enhanced over time in 50/50 co-cultures of ACLcs and MSCs (p≤0.03), but not in other groups. In addition, Collagen-III expression was significantly greater in MSC-only cultures (p≤0.03), but the Collagen-I-to-Collagen-III ratio in 50% co-culture was closest to native ligament levels. Finally, Tenascin-C expression at 4 weeks was significantly higher (p≤0.02) in ACLcs and 50% co-culture groups compared to all others. Immunofluorescent staining results support our mRNA expression data. Overall, 50/50 co-cultures had the highest Collagen-I and Tenascin-C expression, and the highest Collagen-I-to-Collagen-III ratio. Thus, we conclude that using a 50% co-culture of ACLcs and MSCs, instead of either cell population alone, may better maintain or even enhance ligament marker expression and improve healing.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22780864      PMCID: PMC4003471          DOI: 10.1089/ten.TEA.2012.0030

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  40 in total

1.  Vascular physiology and long-term healing of partial ligament tears.

Authors:  Robert C Bray; Catherine A Leonard; Paul T Salo
Journal:  J Orthop Res       Date:  2002-09       Impact factor: 3.494

2.  Selection of cell source for ligament tissue engineering.

Authors:  Zigang Ge; James Cho Hong Goh; Eng Hin Lee
Journal:  Cell Transplant       Date:  2005       Impact factor: 4.064

3.  Ligament tissue engineering: an evolutionary materials science approach.

Authors:  Cato T Laurencin; Joseph W Freeman
Journal:  Biomaterials       Date:  2005-12       Impact factor: 12.479

4.  Enhanced differentiation of mesenchymal stem cells co-cultured with ligament fibroblasts on gelatin/silk fibroin hybrid scaffold.

Authors:  Hongbin Fan; Haifeng Liu; Siew Lok Toh; James C H Goh
Journal:  Biomaterials       Date:  2007-11-26       Impact factor: 12.479

Review 5.  Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.

Authors:  Donald G Phinney; Darwin J Prockop
Journal:  Stem Cells       Date:  2007-09-27       Impact factor: 6.277

6.  Anterior cruciate ligament regeneration using mesenchymal stem cells and silk scaffold in large animal model.

Authors:  Hongbin Fan; Haifeng Liu; Siew L Toh; James C H Goh
Journal:  Biomaterials       Date:  2009-06-18       Impact factor: 12.479

7.  Coculture of human mesenchymal stem cells and articular chondrocytes reduces hypertrophy and enhances functional properties of engineered cartilage.

Authors:  Liming Bian; David Y Zhai; Robert L Mauck; Jason A Burdick
Journal:  Tissue Eng Part A       Date:  2011-01-08       Impact factor: 3.845

Review 8.  Anterior cruciate ligament injury: diagnosis, management, and prevention.

Authors:  Francesca Cimino; Bradford Scott Volk; Don Setter
Journal:  Am Fam Physician       Date:  2010-10-15       Impact factor: 3.292

9.  Comparison of potentials between stem cells isolated from human anterior cruciate ligament and bone marrow for ligament tissue engineering.

Authors:  Ming-Te Cheng; Chien-Lin Liu; Tain-Hsiung Chen; Oscar K Lee
Journal:  Tissue Eng Part A       Date:  2010-07       Impact factor: 3.845

10.  Tissue-engineered trachea from sheep marrow stromal cells with transforming growth factor beta2 released from biodegradable microspheres in a nude rat recipient.

Authors:  Koji Kojima; Ronald A Ignotz; Toshihiro Kushibiki; Kevin W Tinsley; Yasuhiko Tabata; Charles A Vacanti
Journal:  J Thorac Cardiovasc Surg       Date:  2004-07       Impact factor: 5.209

View more
  13 in total

Review 1.  Mechanical Actuation Systems for the Phenotype Commitment of Stem Cell-Based Tendon and Ligament Tissue Substitutes.

Authors:  Marco Govoni; Claudio Muscari; Joseph Lovecchio; Carlo Guarnieri; Emanuele Giordano
Journal:  Stem Cell Rev Rep       Date:  2016-04       Impact factor: 5.739

2.  Mesenchymal stem cells and collagen patches for anterior cruciate ligament repair.

Authors:  Benjamin Gantenbein; Neha Gadhari; Samantha Cw Chan; Sandro Kohl; Sufian S Ahmad
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

3.  Updates in biological therapies for knee injuries: anterior cruciate ligament.

Authors:  Carlos Eduardo da Silveira Franciozi; Sheila Jean McNeill Ingham; Guilherme Conforto Gracitelli; Marcus Vinicius Malheiros Luzo; Freddie H Fu; Rene Jorge Abdalla
Journal:  Curr Rev Musculoskelet Med       Date:  2014-09

4.  Codelivery of Infusion Decellularized Skeletal Muscle with Minced Muscle Autografts Improved Recovery from Volumetric Muscle Loss Injury in a Rat Model.

Authors:  Benjamin Kasukonis; John Kim; Lemuel Brown; Jake Jones; Shahryar Ahmadi; Tyrone Washington; Jeffrey Wolchok
Journal:  Tissue Eng Part A       Date:  2016-09-23       Impact factor: 3.845

Review 5.  In Vitro Innovation of Tendon Tissue Engineering Strategies.

Authors:  Maria Rita Citeroni; Maria Camilla Ciardulli; Valentina Russo; Giovanna Della Porta; Annunziata Mauro; Mohammad El Khatib; Miriam Di Mattia; Devis Galesso; Carlo Barbera; Nicholas R Forsyth; Nicola Maffulli; Barbara Barboni
Journal:  Int J Mol Sci       Date:  2020-09-14       Impact factor: 5.923

6.  Structural and biochemical modification of a collagen scaffold to selectively enhance MSC tenogenic, chondrogenic, and osteogenic differentiation.

Authors:  Steven R Caliari; Brendan A C Harley
Journal:  Adv Healthc Mater       Date:  2014-02-25       Impact factor: 9.933

7.  Cross-Talk Between Human Tenocytes and Bone Marrow Stromal Cells Potentiates Extracellular Matrix Remodeling In Vitro.

Authors:  Emmanuel C Ekwueme; Jay V Shah; Mahir Mohiuddin; Corina A Ghebes; João F Crispim; Daniël B F Saris; Hugo A M Fernandes; Joseph W Freeman
Journal:  J Cell Biochem       Date:  2015-09-29       Impact factor: 4.429

8.  Ligament Tissue Engineering Using a Novel Porous Polycaprolactone Fumarate Scaffold and Adipose Tissue-Derived Mesenchymal Stem Cells Grown in Platelet Lysate.

Authors:  Eric R Wagner; Dalibel Bravo; Mahrokh Dadsetan; Scott M Riester; Steven Chase; Jennifer J Westendorf; Allan B Dietz; Andre J van Wijnen; Michael J Yaszemski; Sanjeev Kakar
Journal:  Tissue Eng Part A       Date:  2015-11       Impact factor: 3.845

9.  A co-culture device with a tunable stiffness to understand combinatorial cell-cell and cell-matrix interactions.

Authors:  Nikhil Rao; Gregory N Grover; Ludovic G Vincent; Samantha C Evans; Yu Suk Choi; Katrina H Spencer; Elliot E Hui; Adam J Engler; Karen L Christman
Journal:  Integr Biol (Camb)       Date:  2013-09-24       Impact factor: 2.192

10.  Extracellular matrix protein production in human adipose-derived mesenchymal stem cells on three-dimensional polycaprolactone (PCL) scaffolds responds to GDF5 or FGF2.

Authors:  Yan Su; Janet M Denbeigh; Emily T Camilleri; Scott M Riester; Joshua A Parry; Eric R Wagner; Michael J Yaszemski; Allan B Dietz; Simon M Cool; Andre J van Wijnen; Sanjeev Kakar
Journal:  Gene Rep       Date:  2017-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.